Immunocore Selects Genedata to Scale Up Discovery of Novel TCR Therapeutics

Basel, Switzerland -- Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, announced today that Immunocore (NASDAQ: IMCR), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, will use Genedata‘s central Scientific Data Management System (SDMS) to scale up [...]

SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

Boston, US, and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an update from the Company’s work with biopharma company Boundless Bio. SOPHiA GENETICS first partnered with Boundless Bio in 2022 to develop and deploy Boundless Bio’s extrachromosomal DNA (ecDNA) detection algorithm as a [...]

AOByte Works with eLabNext to Streamline Custom Add-On Development

BOSTON -- Today, eLabNext, a company that provides digital solutions for the collection, management, and analysis of laboratory information, announced a new collaboration with AOByte, an end-to-end software development service provider. The collaboration between eLabNext and AOByte’s specialized software development tools empowers developers to create both simple and complex add-ons, enhancing the functionality of the digital [...]

SPT Labtech and Synthace partner to accelerate drug discovery through accessible DOE

Cambridge, UK, Boston, USA, and London, UK - SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, and Synthace, the leading digital experiment platform for life science R&D teams, have announced a strategic collaboration to enhance the accessibility and effectiveness of Design of Experiments [...]

Sequentify and Dexter Collaborate to Introduce Genomic Sequencing Solutions to the Romanian Market

REHOVOT, Israel -- Sequentify has partnered with Dexter, a Romanian distributor, to bring Sequentify's InfiniSeq™ library preparation solutions to Romania. This collaboration offers a cost-effective alternative for next-generation sequencing (NGS). Dexter is actively deploying genomic solutions in various laboratories across Romania, expanding access to advanced genomic diagnostics. Sequentify's InfiniSeq reduces sample preparation time to 3.5 hours, from DNA extraction to [...]

Cambridge Isotope Laboratories, Inc. Expands 13C Production Capacity with North Star Project

Tewksbury, MA – Cambridge Isotope Laboratories, Inc. (CIL), the global leader in 13C and 13C urea production, is excited to announce the startup of its North Star project, significantly increasing the company's production capabilities. The North Star project commenced in mid-2020 as the world’s largest 13C production cascade. After the complex build of phase one [...]

PHC Launches LiCellMo™ Live Cell Metabolic Analyzer for Real-Time Visualization of Cellular Metabolism in Cell and Gene Therapies – New Laboratory Technology Emerges from PHC Group Synergy –

PHC Corporation’s Biomedical Division (headquarters: Chiyoda-ku, Tokyo, President: Nobuaki Nakamura; hereafter Biomedical Division) announced today the commercial launch of LiCellMo, a live cell metabolic analyzer that allows researchers to visualize metabolic(*1) changes in cell cultures, providing a more complete picture of cell activity for research uses in cell and gene therapies (CGT). LiCellMo uses PHC’s proprietary [...]

EpiCypher Expands Exclusive Licensing Agreement to Advance CUT&Tag Technology

Durham, NC – EpiCypher®, a trailblazer in epigenetic research technologies, is pleased to announce an exclusive licensing agreement with Fred Hutch Cancer Center. This agreement grants EpiCypher access to pivotal intellectual property (IP) related to CUT&Tag technology, a revolutionary advancement in chromatin profiling developed by renowned scientist Dr. Steven Henikoff, a Fred Hutch molecular biologist [...]

Integrated DNA Technologies Bolsters Comprehensive Genomic Profiling Solutions With Launch of New Archer™ HRD Technology for Cancer Research

Archer CGP research assays now enable homologous recombination deficiency (HRD) assessment for identification of key biomarkers critical for cancer research CORALVILLE, Iowa — With a history of driving innovation and collaboration in next generation sequencing (NGS), Integrated DNA Technologies is expanding its Archer portfolio of comprehensive genomic profiling (CGP) solutions to include homologous recombination deficiency [...]

VedaBio Appoints Dr. G. Brett Robb as Senior Scientific Director and Head of CRISPR Science

Accomplished R&D Leader and CRISPR Tools Expert Joins VedaBio to Drive Platform Expansion and Industrialization SAN DIEGO -- VedaBio, a biotechnology company leading a paradigm shift in molecular detection, today announced the appointment of G. Brett Robb, Ph.D., as Senior Scientific Director and Head of CRISPR Science. With over 16 years of experience in life [...]

Access IBO on Knowledge Center